As I said earlier, there is no point having distributors if we do not have as much production. Can someone please present a back of the envelope calculation to show how much CBD we are getting out of the existing cultivation in Europe? And perhaps what dosage it translates to for the patients?
Another point is that I am not so sure about the value in supplying directly to the patient. I thought it would be more cost effective and more streamlined for MXC to have bulk or large number delivery to the distributor and they can do what they like to do with it (bound by their medico/legal obligations of course). We are a pharma company not running a pharmacy! There will be logistic issues that may not be within MXC's expertise to deal with and which divert our focus.
- Forums
- ASX - By Stock
- RGT
- Ann: Brazil Distribution Agreement signed for MGC Pharma Products
Ann: Brazil Distribution Agreement signed for MGC Pharma Products, page-31
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
30.0¢ | 32.0¢ | 30.0¢ | $31.45K | 98.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4674 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 4326 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4674 | 0.305 |
2 | 3219 | 0.300 |
1 | 15000 | 0.260 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 4326 | 1 |
0.365 | 11528 | 2 |
0.370 | 2000 | 1 |
0.380 | 1522 | 1 |
0.395 | 8746 | 1 |
Last trade - 12.44pm 05/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |